These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18395844)

  • 21. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
    Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.
    el-Zayadi A; Selim O; Haddad S; Simmonds P; Hamdy H; Badran HM; Shawky S
    Ital J Gastroenterol Hepatol; 1999; 31(6):472-5. PubMed ID: 10575565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
    Gerner P; Hilbich J; Wenzl TG; Behrens R; Walther F; Kliemann G; Enninger A; Wirth S
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):187-90. PubMed ID: 20512050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA; Bozorg B; Rosenstein DL
    Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating hepatitis C in "difficult-to-treat" patients.
    Pawlotsky JM
    N Engl J Med; 2004 Jul; 351(5):422-3. PubMed ID: 15282348
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic hepatitis C virus infection.
    Flamm SL
    JAMA; 2003 May; 289(18):2413-7. PubMed ID: 12746366
    [No Abstract]   [Full Text] [Related]  

  • 27. Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection.
    Sagir A; Heintges T; Akyazi Z; Oette M; Erhardt A; Häussinger D
    Liver Int; 2007 Sep; 27(7):954-9. PubMed ID: 17696934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evolution of hepatitis C treatment: individualized therapy.
    Smith JR; Herrera JL
    Am J Gastroenterol; 2000 Sep; 95(9):2383. PubMed ID: 11007249
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin.
    Tang KH; Herrmann E; Pachiadakis I; Paulon E; Tatman N; Zeuzem S; Naoumov NV
    Aliment Pharmacol Ther; 2008 May; 27(9):810-9. PubMed ID: 18221408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH; Seeff LB
    N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract]   [Full Text] [Related]  

  • 31. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.
    Shiffman ML; Rustgi VK
    Gastroenterology; 2006 Oct; 131(4):1339-41. PubMed ID: 17030201
    [No Abstract]   [Full Text] [Related]  

  • 33. No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.
    Bonkovsky HL; Salek J
    Gastroenterology; 2005 Oct; 129(4):1361-2. PubMed ID: 16230097
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C.
    Carr C; Hollinger FB; Yoffe B; Wakil A; Phillips J; Bzowej N; Leung J; Mirro K; Poordad F; Moore DH; Gish RG
    Liver Int; 2007 Oct; 27(8):1111-8. PubMed ID: 17845540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiviral therapy for patients with chronic hepatitis C].
    Takehara T; Hayashi N
    Nihon Shokakibyo Gakkai Zasshi; 2001 May; 98(5):512-24. PubMed ID: 11400279
    [No Abstract]   [Full Text] [Related]  

  • 36. Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.
    Morsica G; De Bona A; Foppa CU; Sitia G; Finazzi R; Lazzarin A
    AIDS; 2000 Jul; 14(11):1656-8. PubMed ID: 10983654
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic hepatitis C.
    Davis GL
    BMJ; 2001 Nov; 323(7322):1141-2. PubMed ID: 11711386
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of interferon and ribavirin on HIV viral load.
    Landau A; Batisse D; Piketty C; Kazatchkine MD
    AIDS; 2000 Jan; 14(1):96-7. PubMed ID: 10714577
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C.
    Bruchfeld A; Ståhle L; Andersson J; Schvarcz R
    Nephrol Dial Transplant; 2001 Aug; 16(8):1729. PubMed ID: 11477195
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment options in patients with chronic hepatitis C.
    Burak KW; Lee SS
    Can J Public Health; 2000; 91 Suppl 1():S22-6, S24-8. PubMed ID: 11059126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.